Introducing The PaloVia(TM) Skin Renewing Laser(TM) From Palomar Medical Technologies, Inc.
The First FDA-Cleared, At-Home Laser Clinically Proven to Reduce Fine Lines and Wrinkles Around the Eyes
Palomar to Host Analyst and Investor Meeting in NYC
BURLINGTON, Mass., Dec. 15, 2010 (GLOBE NEWSWIRE) -- Palomar Medical Technologies, Inc. (Nasdaq:PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, today announced the launch of the first FDA-cleared, at-home laser clinically proven to reduce fine lines and wrinkles around the eyes – the PaloVia Skin Renewing Laser. Palomar will host an analyst and investor meeting to discuss its launch plans in New York City on January 6, 2011 from 10AM to 12PM at the Nasdaq MarketSite, 4 Times Square, second floor Press Conference Room. Attendees from Palomar will be Joseph Caruso, Chief Executive Officer; Paul Weiner, Chief Financial Officer; Nancy Teumer, Global Marketing Director Consumer Products; David Montgomery, Consumer Products Sales Director; and Richard Bankowski, Field Clinical Director and QVC Spokesperson. Also in attendance will be one of Palomar's PaloVia Expert Panel Members Dr. Robert Weiss, Director, Maryland Laser, Skin & Vein Institute. For analysts and investors that are not able to attend the PaloVia launch meeting in New York City, the meeting will also be accessible via webcast in the About Palomar/Investors section of Palomar's website at palomarmedical.com.As an industry leader and pioneer in the science of using lasers and light to improve personal appearance, Palomar's patented fractional technology has been proven by dermatologists worldwide for more than a decade. Now, for the first time ever, this same technology has been adapted and perfected for use at home, delivering a visible improvement in fine lines and wrinkles. In a clinical study, a panel of doctors specializing in dermatology and plastic surgery saw a noticeable reduction in wrinkles in 92% of participants after one month of daily treatments.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV